Keyphrases
Single-photon Emission Computed Tomography (SPECT)
84%
Dopamine Transporter
61%
123I
47%
Striatal Dopamine
36%
PE2I
32%
Dopamine Transporter SPECT
28%
Translocator Protein
24%
Striatal
19%
123I-FP-CIT SPECT
18%
A1 Receptor
18%
Glucagon-like
18%
Radioligand
17%
Dopamine Transporter Binding
16%
Receptor Agonist
14%
SISCOM
14%
Methodological Considerations
14%
Epilepsy
14%
SPECT Imaging
14%
Pre-surgical
14%
Interictal
14%
Ictal
14%
Region of Interest
14%
Predictive Value
14%
Nortropane
13%
Exenatide
12%
Glioblastoma multiforme
11%
Volume-of-interest
11%
Molecular Imaging
10%
Brain Scans
9%
Seizure Duration
8%
Healthy Volunteers
8%
Exenatide Once Weekly
8%
Healthy Controls
8%
Acetamide
8%
Pyridine-3
8%
Placebo-controlled Clinical Trial
8%
Imidazo
8%
Brain Imaging
8%
Chloro
8%
Gadolinium
8%
Alcohol Intake
8%
Positive Predictive Value
8%
Healthy Individuals
7%
Patients with Parkinson's Disease
7%
Enzyme-linked Immunosorbent Assay (ELISA)
7%
Neuroinflammation
7%
Magnetic Resonance Imaging
7%
Hypoperfusion
7%
Active Smokers
7%
Automatic Delineation
7%
Neuroscience
Single-Photon Emission Computed Tomography
100%
Iodine-123
80%
Dopamine Transporter
71%
Translocator Protein
31%
In Vivo
21%
Exenatide
15%
Glucagon-Like Peptide-1 Agonist
14%
Technetium-99m
14%
Ictal
14%
Placebo
14%
Radioligand
12%
Dopaminergic
11%
Magnetic Resonance Imaging
10%
Molecular Imaging
9%
Magnetic Resonance Imaging
9%
Glucagon-Like Peptide 1 Receptor
9%
Glioblastoma Multiforme
9%
Parkinson's Disease
9%
Positron Emission Tomography
9%
Acetamide
8%
Pyridine
8%
Body Mass Index
8%
Protein Expression
7%
Dopamine Uptake
7%
Post-Concussion Syndrome
7%
Dementia with Lewy Bodies
7%
Neurotrauma
7%
Arterial Spin Labeling
7%
Traumatic Brain Injury
7%
Protein Binding
7%
Neurodegeneration
7%
Brain-Derived Neurotrophic Factor
7%
Serotonin Transporter
7%
Fluorine-18
7%
Multiple System Atrophy
7%
Acetazolamide
7%
